Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shire

Shire
1986 FOUNDED
M&A STATUS
20K-25K EMPLOYEES
M&A LATEST DEAL TYPE
$58.6B LATEST DEAL AMOUNT
Description

Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • Block 2 & 3 Miesian Plaza
  • 50-58 Baggot Street Lower
  • Dublin 2
  • Ireland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Shire’s full profile, request a free trial.

Shire Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 08-Jan-2019 $58.6B 00000 000.00 Completed Profitable
4. Merger/Acquisition 20-Oct-2014 0000 0000 Cancelled Profitable
3. PIPE 20-Feb-2007 00000 00000 Completed Profitable
2. IPO 15-Feb-1996 Completed Profitable
1. Early Stage VC Completed Profitable
To view this company’s complete deal history including valuation and funding, request access »

Shire Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alexion Formerly VC-backed Boston, MA 0000 000000&0
00000000 000000000 Corporation Durham, NC 000 000.00 000000 - 000 000.00
000 Formerly PE-Backed Brussels, Belgium 0000 00000 000000 - 000 00000
0000000 Formerly VC-backed Summit, NJ 0000 000.00 000000&0 000.00
00000 000000000000 Formerly VC-backed Bridgewater, NJ 0000 00000 000000&0
To view this company’s complete list of competitors, request access »

Shire Investments & Acquisitions (49)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 06-Sep-2018 000000000000000000 Laboratory Services (Healthcare)
00000 000000000000 04-Jun-2018 00000 00000 00 000.00 Biotechnology
0000 000000000000 22-Dec-2017 00000 00000 00 000.00 Drug Delivery
000000 000000 30-Jun-2017 000000000000000000 Pharmaceuticals
OncoResponse 23-Mar-2017 Early Stage VC 000.00 Biotechnology
To view this company’s complete investment and acquisition history, request access »

Shire Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 02-Jun-2016 0000 000.00 Completed
  • 7 buyers
0000000000 0000000 20-Dec-2012 00000 00000 00 0000 Completed
  • 11 buyers
DBV Technologies 05-Jan-2011 Later Stage VC 000.00 Completed
  • 8 buyers
To view this company’s complete exits history, request access »

Shire Subsidiaries (4)

Company Name Industry Location Founded
Lumena Pharmaceuticals Drug Discovery San Diego, CA 2011
00000 000000000 00 Corporate Venture Capital Wayne, PA 0000
0000000000 Laboratory Services (Healthcare) Herisau, Switzerland 0000
000 00000 00000000 Pharmaceuticals Radford, VA 0000
To view this company’s complete subsidiary history, request access »

Shire Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
HealthCare Ventures Venture Capital Minority 000 0000 000000 0
Permira PE/Buyout Minority 000 0000 000000 0
SV Health Investors Venture Capital Minority 000 0000 000000 0